List view / Grid view

Young Kwon (Alchemab Therapeutics)

 

article

Huntington’s disease and potential therapies

In this exclusive interview with Young Kwon, CEO of Alchemab,…

22 August 2023 | By

In this exclusive interview with Young Kwon, CEO of Alchemab, we discuss new platforms that are revolutionising how researchers identify naturally occurring antibodies in resilient individuals, opening up new possibilities for the development of disease-modifying therapies.